Movatterモバイル変換


[0]ホーム

URL:


CN101229075A - Asherman's syndrom curer - Google Patents

Asherman's syndrom curer
Download PDF

Info

Publication number
CN101229075A
CN101229075ACNA2008100307118ACN200810030711ACN101229075ACN 101229075 ACN101229075 ACN 101229075ACN A2008100307118 ACNA2008100307118 ACN A2008100307118ACN 200810030711 ACN200810030711 ACN 200810030711ACN 101229075 ACN101229075 ACN 101229075A
Authority
CN
China
Prior art keywords
estrogen
release device
asherman
syndrom
curer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2008100307118A
Other languages
Chinese (zh)
Inventor
徐大宝
薛敏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IndividualfiledCriticalIndividual
Priority to CNA2008100307118ApriorityCriticalpatent/CN101229075A/en
Publication of CN101229075ApublicationCriticalpatent/CN101229075A/en
Pendinglegal-statusCriticalCurrent

Links

Images

Landscapes

Abstract

The invention discloses a uterine cavity adhesion curing device, including a uterine shaped ring and an estrogen slow release device. The estrogen slow release device is connected on the uterine shaped ring. As the uterine shaped ring is connected with the estrogen slow release device, a medicine can be partially used on a uterine cavity in a human body, which can not bring a side effect as much as that of taking the estrogen with big dosage orally. As applying the medicine partially has pertinence and better curing effect, the invention can also save the medicine dosage and reduce the curing cost.

Description

Asherman's syndrom curer
Technical field
The present invention relates to a kind of gynecological Asherman's syndrom curer, belong to technical field of medical instruments.
Background technology
Intrauterine adhesion is because the impaired back of inner membrane of uterine cavity forms the pathological phenomenon of part or all of adhesion.Usually can cause irregular menstruation, as hypomenorrhea or amenorrhea etc.The patient miscarries easily, premature labor, ectopic pregnancy, fetal death in utero, Placenta Hominis implantation, placental adherence even infertile.The general employing earlier of intrauterine adhesion operation for severe at present separates uterine cavity.Because it is very poor that the postoperative inner membrane of uterine cavity is regenerated slowly or regenerated, the uterine cavity after the separation is very easy to adhesion once more.In order to solve the postoperative uterine cavity problem of adhesion once more, need in uterine cavity, to place the estrogen of ring and n of high dose oral to stimulate the inner membrane of uterine cavity growth.But a large amount of oral estrogens is known from experience the people and is caused very big side effect, as to the infringement of liver, cause the mammary gland canceration, increase the body fluid storage and stay, change coagulation function etc.Simultaneously a large amount of exogenous hormones enter body can make the people become pathological state by the physiological state because negative feedback inhibition human body endogenous hormones produces.
Summary of the invention
The purpose of this invention is to provide a kind of Asherman's syndrom curer very little to the human body side effect.
For achieving the above object, the present invention includes uterus shape contraceptive ring and estrogen delayed release device, described estrogen delayed release device is connected on the uterus shape contraceptive ring.
As improvement of the present invention, described uterus shape contraceptive ring is a palace shape rustless steel elastic ring.
As further improvement, described estrogen delayed release device comprises vertical pole, and vertical pole has micropore on the surface, and the estrogen slow-released system is housed in the vertical pole.
Owing to be connected with the estrogen delayed release device on uterus shape contraceptive ring, local application in the uterine cavity of human body only can not bring big side effect the estrogen that resembles n of high dose oral to human body.Because agents area is targeted, therapeutic effect is also better, can also save medication amount, reduces medical expense.
Description of drawings
Fig. 1 is a kind of specific embodiment sketch map of the present invention.
The specific embodiment
Below in conjunction with accompanying drawing Asherman's syndrom curer of the present invention is described further.
As shown in Figure 1, the present invention includes uterus shape contraceptive ring 1 andvertical pole 2, uterus shape contraceptive ring 1 is a palace shape rustless steel elastic ring, andvertical pole 2 is connected on the uterus shape contraceptive ring.Vertical pole hasmicropore 3 on 2 surfaces, and the estrogen slow-released system is housed in the vertical pole 2.After adopting operation to separate the uterine cavity of adhesion, Asherman's syndrom curer of the present invention is put into intrauterine, uterus shape contraceptive ring 1 can prevent uterine cavity adhesion once more, the estrogen slow-released system that is equipped with in thevertical pole 2 can discharge estrogen lentamente by themicropore 3 on vertical pole surface in uterine cavity, promote the inner membrane of uterine cavity growth, thoroughly cure intrauterine adhesion.The present invention can be placed on the treatment time of uterine cavity according to state of an illness needs decisions, also can take out when not required, and it is good to have a therapeutic effect, safety and side effect is little, the treatment low cost and other advantages.
The invention is not restricted to the shape shown in the accompanying drawing,, reach its technique effect, all within protection domain of the present invention so long as can realize technical scheme of the present invention as previously mentioned.

Claims (3)

CNA2008100307118A2008-02-272008-02-27Asherman's syndrom curerPendingCN101229075A (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
CNA2008100307118ACN101229075A (en)2008-02-272008-02-27Asherman's syndrom curer

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
CNA2008100307118ACN101229075A (en)2008-02-272008-02-27Asherman's syndrom curer

Publications (1)

Publication NumberPublication Date
CN101229075Atrue CN101229075A (en)2008-07-30

Family

ID=39896106

Family Applications (1)

Application NumberTitlePriority DateFiling Date
CNA2008100307118APendingCN101229075A (en)2008-02-272008-02-27Asherman's syndrom curer

Country Status (1)

CountryLink
CN (1)CN101229075A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN102120059A (en)*2011-03-112011-07-13东南大学Medicinal stent-graft for preventing and treating intrauterine adhesion
CN102860895A (en)*2011-07-052013-01-09上海林静医疗器械有限公司Pessary with slow-release support
CN103301558A (en)*2013-06-252013-09-18杭州安体科技有限公司Inductive uterine slow release system

Cited By (3)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN102120059A (en)*2011-03-112011-07-13东南大学Medicinal stent-graft for preventing and treating intrauterine adhesion
CN102860895A (en)*2011-07-052013-01-09上海林静医疗器械有限公司Pessary with slow-release support
CN103301558A (en)*2013-06-252013-09-18杭州安体科技有限公司Inductive uterine slow release system

Similar Documents

PublicationPublication DateTitle
EP3131594B1 (en)Drainage system and vacuum pump for intrauterine vacuum therapy
CN203647443U (en)Device for preventing adhesion of uterine cavity mucosa
CN103637836A (en)Intrauterine adhesion prevention and treatment device
WO2014106315A1 (en)Intrauterine implant
PE20060467A1 (en) TREATMENT OF DISRUPTION HEMORRHAGE IN EXTENDED CONTRACEPTIVE REGIMES
CN102648868B (en)Intrauterine adhesion prevention and cure device
KR100508818B1 (en)Intrauterine Device that prevent adhesion of endometrium from recurring
SkidmoreReproduction in the dromedary camel.
CN101229075A (en)Asherman's syndrom curer
CN201161050Y (en)Instrument for treating uterine cavity synechiac
CN201161051Y (en)Device for treating uterine cavity synechiac
WO2012030252A1 (en)Method for increasing the possibility of successful implantation of an embryo into the endometrium of a uterine cavity
CN205515128U (en) An inverted triangular intrauterine device capable of preventing and treating uterine fibroids
CN202537620U (en)Preventing and treating device for uterine cavity adhesion
CN101229074A (en)Asherman's syndrom curing equipment
CN201618299U (en)Intrauterine medicine slow-release device
CN204049791U (en)The device of control intrauterine adhesion
CN205626243U (en)A birth control ware for preventing and treat adhesion of palace chamber
CN204049793U (en)Intrauterine adhesion control device
CN204698792U (en)A patch for preventing and treating diseases by sealing male urethral orifice
CN204049792U (en)Uterus septus TURP and after the sidewall orthopaedy of left and right intrauterine adhesion control device
CN201189193Y (en)Intrauterine adhesions therapeutic equipment
CN210521178U (en)Gourd-shaped hollow contraceptive device
CN209548196U (en)A kind of intrauterine device of novel prevention Asherman's syndrom
CN203802944U (en)Treatment support for cervicitis

Legal Events

DateCodeTitleDescription
C06Publication
PB01Publication
C10Entry into substantive examination
SE01Entry into force of request for substantive examination
C12Rejection of a patent application after its publication
RJ01Rejection of invention patent application after publication

Open date:20080730


[8]ページ先頭

©2009-2025 Movatter.jp